Michal Haran

1PUBLICATIONS
1CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|May 04, 2017
A phase I-II clinical trial of the anti-CD74 monoclonal antibody milatuzumab in frail patients with refractory chronic lymphocytic leukaemia: A patient based approach.

Michal Haran, Vita Mirkin, Andrei Braester

Pageof 1

Frequent Collaborators

1 joint publications

Yair Herishanu